Angiodynamics ANGO
NASDAQ ANGO
$11.89 +0.08 (+0.68%)
At close: Oct 21, 2026 · 4:00 PM EDT

Angiodynamics (ANGO) Liabilities and Shareholders Equity (2011 - 2026)

Updated

Angiodynamics (ANGO) recorded Liabilities and Shareholders Equity of $241.93 million in fiscal Q1 2027 (quarter ended Aug 31, 2026), down 8.9% from $265.64 million a year earlier and down 9.4% from the prior quarter.

Analysis

Angiodynamics (ANGO) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended May 31, 2026), Angiodynamics reported Liabilities and Shareholders Equity of $267.16 million, down 4.6% from FY2025.

  • Annual Liabilities and Shareholders Equity has declined for seven straight fiscal years, with a five-year compound annual growth rate of -13.8% (FY2021 to FY2026).
  • Across earlier fiscal years, Liabilities and Shareholders Equity came in at $280.14 million in FY2025 (-11.8%), $317.67 million in FY2024 (-40.4%), $532.64 million in FY2023 (-3.6%) and $552.75 million in FY2022 (-1.5%).
  • The fiscal Q1 2027 figure is the lowest quarterly Liabilities and Shareholders Equity in data going back to fiscal Q4 2011.
  • On a year-over-year basis, Liabilities and Shareholders Equity has declined for 15 consecutive quarters, with an average decline of 13.1% over the last eight quarters.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 0.7% in fiscal Q2 2023, against a decline of 41.6% in fiscal Q2 2025 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $267.16 million (Q4 2026), $260.68 million (Q3 2026) and $269.68 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn 109.22 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn 20.88 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn 93.31 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn 45.22 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn 50.73 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 13.87 Bn
10 Angiodynamics 499.01 Mn 331.73 Mn 48.04 Mn 241.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 241.93 Mn
May 31, 2026 267.16 Mn
Feb 28, 2026 260.68 Mn
Nov 30, 2025 269.68 Mn
Aug 31, 2025 265.64 Mn
May 31, 2025 280.14 Mn
Feb 28, 2025 285.42 Mn
Nov 30, 2024 291.60 Mn
Aug 31, 2024 293.63 Mn
May 31, 2024 317.67 Mn
Feb 29, 2024 324.84 Mn
Nov 30, 2023 499.62 Mn
Aug 31, 2023 493.95 Mn
May 31, 2023 532.64 Mn
Feb 28, 2023 542.85 Mn
Nov 30, 2022 558.21 Mn
Aug 31, 2022 557.70 Mn
May 31, 2022 552.75 Mn
Feb 28, 2022 543.18 Mn
Nov 30, 2021 554.10 Mn
API Access

Angiodynamics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ANGO&period=max&api_key=YOUR_API_KEY